Use of Empagliflozin to Treat Prediabetes
Clinical trial NCT05426525 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05426525
- Sponsor
- Oregon State University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-13
- Primary completion
- 2026-05-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.